Magellan Health

Magellan Health provides managed care services for some of the areas of healthcare. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. The company operates the following segments: Healthcare, which consists of the following reporting units, Behavioral and Specialty Health, and Magellan Complete Care; and Pharmacy Management, which is comprised of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit.
  • TickerMGLN
  • ISINUS5590792074
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Moody's announces completion of a periodic review of ratings of Magellan Health, Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Magellan Health, Inc.. Global Credit Research- 03 Feb 2021. New York, February 03, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Magellan Health, Inc. and other ratings that are associated with the same analytical unit.

With a more favourable environment, MAGELLAN HEALTH improves to Positive

MAGELLAN HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date January 29, 2021, the closing price was USD 93.98 and its potential was estimated at USD 114.24.

Moody's continues rating review of Magellan Health

Announcement: Moody's continues rating review of Magellan Health. Global Credit Research- 04 Jan 2021. New York, January 04, 2021-- Moody's Investors Service commented that the ratings of Magellan Health, Inc. remain under review for downgrade following the announcement that Centene Corporation will acquire Magellan for approximately $2.2 billion in enterprise value.

MarketLine Department

CIGNA Corporation - Strategy, SWOT and Corporate Finance Report

Summary CIGNA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights CIGNA Corporation (CIGNA or 'the company') is a health services organization that offers medical, dental, pharmacy, behavioral, disability, life and accident insurance and related products and services. The company offers supplemental health, life and accident insurance products and health...

MarketLine Department

Centene Corporation - Strategy, SWOT and Corporate Finance Report

Summary Centene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Centene Corporation (Centene or 'the company') is a diversified multi-national healthcare enterprise that provides healthcare services to uninsured and under-insured individuals. The company offers services through the US government's healthcare programs such as Medicaid, Medicare, the S...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Many Consumer Discretionary names are staging reversals or developing bullish bases. (ex. CPRI, CRI, OXM, PENN, LOCO, PZZA, DPZ, WW, CHS, ZUMZ, and GES) • The Healthcare Sector has a significant number of names reversing downtrend, breaking out of bases, and in uptrends (ex. CAH, TCMD, THC, SEM, MGLN, RGEN, REGN, MEDP, PRAH, and BMY) • Semis and Semi suppliers continue to develop positively. (ex. UCTT, ICHR, FORM, AEIS, and BRKS)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Energy related names are reversing price and RS downtrends. (ex. DRQ, OII, AROC, and CKH) • A few banks and asset managers are inflecting positively or within uptrends. (ex. C, BRKL, VLY, FCF, LM, and INTL) • The healthcare Sector has a number of names inflecting bullishly (ex. CUTR, CMD, IART, CCRN, CRVL, MGLN, PGNX, ANIK, ILMN, IQV, and ANIP)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Many Media related names are topside major bases and remains leadership. (ex. OMC, DISCA) • Auto Dealerships are showing significant strength. (ex. SAH, LAD, AN,and GPI) • Credit Card companies are staging price and RS reversals (ex. COF, and DFS) • Education stocks remains leadership and are building bases. (ex APEI, STRA, and CECO)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders and Auto Parts suppliers continue to stage price and RS reversals. • A number of Industrial Manufacturing are in the process of reversing price and RS downtrends or forming bullish bases. • Semiconductors and Semi-Suppliers continue to be leadership with many breaking topside of bases and staging price and RS reversals.

MarketLine Department

CIGNA Corporation - Strategy, SWOT and Corporate Finance Report

Summary CIGNA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights CIGNA Corporation (CIGNA or 'the company') is a health services organization that offers medical, dental, pharmacy, behavioral, disability, life and accident insurance and related products and services. The company offers supplemental health, life and accident insurance products and health...

MarketLine Department

Centene Corporation - Strategy, SWOT and Corporate Finance Report

Summary Centene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Centene Corporation (Centene or 'the company') is a diversified multi-national healthcare enterprise that provides healthcare services to uninsured and under-insured individuals. The company offers services through the US government's healthcare programs such as Medicaid, Medicare, the S...

MarketLine Department

Centene Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Centene Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Centene Corp since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highligh...

MarketLine Department

Cigna Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Cigna Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cigna Corp since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights ...

Valens Research

UAFRS vs As Reported Weekly Highlights - 2019 03 13

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for FIS, MYL, and MGLN.

Moody's announces completion of a periodic review of ratings of Magellan Health, Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Magellan Health, Inc.. Global Credit Research- 03 Feb 2021. New York, February 03, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Magellan Health, Inc. and other ratings that are associated with the same analytical unit.

Moody's continues rating review of Magellan Health

Announcement: Moody's continues rating review of Magellan Health. Global Credit Research- 04 Jan 2021. New York, January 04, 2021-- Moody's Investors Service commented that the ratings of Magellan Health, Inc. remain under review for downgrade following the announcement that Centene Corporation will acquire Magellan for approximately $2.2 billion in enterprise value.

Magellan Health, Inc.: Update following change to ratings under review for downgrade

Our credit view of Magellan reflecting diverse service offerings and modest financial leverage offset by reduced scale and diversity from the anticipated sale of Magellan Complete Care.

Moody's reviews Magellan Health's ratings for downgrade

Rating Action: Moody's reviews Magellan Health's ratings for downgrade. Global Credit Research- 01 May 2020. New York, May 01, 2020-- Moody's Investors Service placed the ratings of Magellan Health, Inc. under review for downgrade.

Moody's reviews Magellan Health's ratings for downgrade

Rating Action: Moody's reviews Magellan Health's ratings for downgrade. Global Credit Research- 01 May 2020. New York, May 01, 2020-- Moody's Investors Service placed the ratings of Magellan Health, Inc. under review for downgrade.

With a more favourable environment, MAGELLAN HEALTH improves to Positive

MAGELLAN HEALTH (US), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date January 29, 2021, the closing price was USD 93.98 and its potential was estimated at USD 114.24.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch